Hasselt | Jotup

Biomed 2024, Israel's Leading Annual Life Science Conference and Exhibition, May 21-23, in Tel Aviv

Retrieved on:

Giovedì, Aprile 18, 2024

Medtech, InterContinental, TEL, Hope, Hasselt, Uncertainty, MD, Doctor of Philosophy, Medicine, ONE, Digital, Pathology, Senior, Cardiovascular disease, Deficit spending, Ageing, Drug discovery, Knowledge

TEL AVIV, Israel, April 18, 2024 /PRNewswire/ -- Biomed Israel , the premier international Life Science and HealthTech conference in Israel, will take place on May 21-23, 2024, at the David InterContinental Hotel in Tel Aviv, Israel.

Key Points:

TEL AVIV, Israel, April 18, 2024 /PRNewswire/ -- Biomed Israel , the premier international Life Science and HealthTech conference in Israel, will take place on May 21-23, 2024, at the David InterContinental Hotel in Tel Aviv, Israel.
The event presents a unique opportunity for global healthcare and HealthTech leaders to experience Israel's innovative and vibrant life science and biomedical industry.
As in previous years, more than 100 Israeli life science companies, both promising startups and more established companies, will present and exhibit their innovative products and technologies.
"The first and foremost objective of Biomed Israel is to boost collaborations between the innovative HealthTech ecosystem in Israel and the global life science industry.

AiRISTA Hires Diederik Houben as VP of Product Management

Retrieved on:

Giovedì, Gennaio 4, 2024

Diederik, Telecommunications, MIT, Business administration, Product management, Physics, CommScope, Hasselt, University, Engineering, Institute of technology, Management

SPARKS, Md., Jan. 4, 2024 /PRNewswire/ -- AiRISTA , a leader in Real Time Location Services solutions (RTLS), is pleased to announce the addition of Diederik Houban to its leadership team as Vice President of Product Management.

Key Points:

SPARKS, Md., Jan. 4, 2024 /PRNewswire/ -- AiRISTA , a leader in Real Time Location Services solutions (RTLS), is pleased to announce the addition of Diederik Houban to its leadership team as Vice President of Product Management.
Together with AiRISTA partners, he will ensure the highest levels of solution quality and the resulting customer value.
Diederik, previously VP & GM at Cable Exchange, a CommScope division, brings extensive executive experience.
Prior to his role at CommScope, Diederik held key global positions in engineering, business development, and product management within the automotive and telecommunications sectors.

AUS WELCOMES RHIANNON THURMOND -- Social Media Influencer and Texas Field Service Engineer

Retrieved on:

Giovedì, Agosto 3, 2023

Field service management, Hasselt, AIS, Hospital, Internet, Biomedicine, UBS, Family, Social media, Medical imaging, Greater Houston

TUSLA, Okla., Aug. 3, 2023 /PRNewswire/ -- Advanced Ultrasound Systems (AUS), a leading provider of ultrasound equipment, parts, probes, service, and training announces the appointment of Rhiannon Thurmond as the company's newest Field Service Engineer. In this role, she will be responsible for developing and managing service relationships with clinics and hospitals in the Texas region.

Key Points:

Now with 7,500+ followers, she is an influencer with an active social media presence sparking thoughtful conversations with her biomed and clinical engineering audience.
TUSLA, Okla., Aug. 3, 2023 /PRNewswire/ -- Advanced Ultrasound Systems (AUS), a leading provider of ultrasound equipment, parts, probes, service, and training announces the appointment of Rhiannon Thurmond as the company's newest Field Service Engineer.
In this role, she will be responsible for developing and managing service relationships with clinics and hospitals in the Texas region.
With over 16 years of multi-vendor, multi-modality experience servicing medical devices and equipment, Thurmond has built a solid biomedical and field service engineering foundation.

Claroty's Team82 Gears Up for Multiple Talks at Black Hat USA and DEF CON

Retrieved on:

Mercoledì, Luglio 26, 2023

NEW YORK, July 26, 2023 /PRNewswire/ -- Claroty, the cyber-physical systems protection company, today announced that Team82, its award-winning research team, will descend on Las Vegas next month for talks at Black Hat USA and DEF CON, two of the biggest cybersecurity conferences of the year. Team82's Sharon Brizinov, director of vulnerability research, and Noam Moshe, vulnerability researcher, will present two sessions at each show.

Key Points:

For the past two years, Team82 has been researching dozens of OPC-UA protocol stack implementations being used in millions of industrial products.
Moshe and Brizinov focused on two main attack vectors: attacking OPC-UA servers and protocol gateways, and attacking OPC-UA clients.
The research yielded unique attack techniques that targeted specific OPC-UA protocol implementation pitfalls that enabled Team82 to create a wide range of vulns ranging from denial of service to remote code execution.
For example, researchers explored OPC-UA features such as method call processing, chunking mechanisms, certification handling, complex variant structures, monitored items, race-conditions, and many more.

Clinical asset management leader TRIMEDX announces launch of Vigilor, an expansion of its medical device cybersecurity solution as independent services to all health systems

Retrieved on:

Mercoledì, Luglio 26, 2023

NIST, Informatics, Pressure, Medicine, Risk management, Hasselt, Attention, Hospital, Patient safety, Risk, OEM, Health, Safety, Legislation, Medical device

Indianapolis, Indiana, July 26, 2023 (GLOBE NEWSWIRE) -- TRIMEDX―an industry-leading, independent clinical asset management company delivering clinical engineering services, clinical asset informatics, and medical device cybersecurity―announced the launch of Vigilor, independent cybersecurity services available to all health systems.

Key Points:

Indianapolis, Indiana, July 26, 2023 (GLOBE NEWSWIRE) -- TRIMEDX―an industry-leading, independent clinical asset management company delivering clinical engineering services, clinical asset informatics, and medical device cybersecurity―announced the launch of Vigilor, independent cybersecurity services available to all health systems.
Vigilor from TRIMEDX is a comprehensive closed-loop medical device cybersecurity program working with health systems’ existing clinical engineering, biomed, and IT security teams, as well as technology and processes.
With Vigilor from TRIMEDX, health systems can establish full visibility of network-capable medical device inventory and improve inventory accuracy up to 95% or more.
With Vigilor, health systems have dedicated cyber support specialists to monitor a health system’s cybersecurity program and provide prioritized & actionable steps to carry out critical work & remediations necessary to maintain a health system’s cyber-risk posture.

BlackPearl Technology, Inc. Receives 2023 IoT Evolution Product of the Year Award

Retrieved on:

Giovedì, Luglio 13, 2023

Industrial internet of things, Aerospace Journalist of the Year Awards, Trusted Platform Module, TPM, Internet of things, Interceptor, Hasselt, TMC, Robotics, Environment, Automation, Customer service

THE WOODLANDS, Texas, July 13, 2023 /PRNewswire-PRWeb/ -- BlackPearl Technology, Inc., an industry titan in creating cutting-edge technology, has clinched the prestigious 2023 IoT Evolution Product of the Year Award. This honor, announced by TMC and Crossfire Media on July 11, 2023, sets a new benchmark in the IoT industry.

Key Points:

THE WOODLANDS, Texas, July 13, 2023 /PRNewswire-PRWeb/ -- BlackPearl Technology, Inc., an industry titan in creating cutting-edge technology, has clinched the prestigious 2023 IoT Evolution Product of the Year Award.
This honor, announced by TMC and Crossfire Media on July 11, 2023, sets a new benchmark in the IoT industry.
The IoT Evolution Product of the Year Award is a herald of innovation, paying homage to the most groundbreaking products and solutions revolutionizing the IoT sphere.
"The solutions selected for the IoT Evolution Product of Year Award reflect the diverse range of innovation driving the multi-billion dollar IoT market today.

EQS-News: Mainz Biomed Processes First Patients from Colorectal Cancer Screening Campaign Through its Corporate Health Portal in Partnership with Zöller-Kipper

Retrieved on:

Sabato, Maggio 27, 2023

Partnership, CRC, Cancer, BGM, Patient, Physician, Colorectal cancer, Hasselt, HR, Diagnosis, Health, Pharmaceutical industry, Medical imaging

In April 2023, Zöller-Kipper selected ColoAlert®, Mainz Biomed’s highly efficacious and easy-to-use screening test for CRC, for its corporate health program.

Key Points:

In April 2023, Zöller-Kipper selected ColoAlert®, Mainz Biomed’s highly efficacious and easy-to-use screening test for CRC, for its corporate health program.
As part of its commitment to the BGM program, Mainz Biomed provided education to employees and physicians on CRC and recommendations for next steps.
“Mainz Biomed made it easy for us to quickly implement ColoAlert as one of our BGM options,” said Irina Riffel, Head of HR of Zöller-Kipper.
“Our employees are able to readily access the patient portal, request a kit and securely receive their results within five days.

Mainz Biomed Processes First Patients from Colorectal Cancer Screening Campaign Through its Corporate Health Portal in Partnership with Zöeller-Kipper

Retrieved on:

Mercoledì, Maggio 24, 2023

Partnership, CRC, Cancer, BGM, Patient, Physician, Colorectal cancer, Hasselt, HR, Diagnosis, Health, Pharmaceutical industry, Medical imaging

BERKELEY, Calif. and MAINZ, Germany, May 24, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today initial results from its colorectal cancer (CRC) screening campaign through its BGM (“betriebliches Gesundheitsmanagement”) partnership with Zöeller-Kipper GmbH, part of the Zöeller group with more than 2,500 employees. In April 2023, Zöeller-Kipper selected ColoAlert®, Mainz Biomed’s highly efficacious and easy-to-use screening test for CRC, for its corporate health program.

Key Points:

In April 2023, Zöeller-Kipper selected ColoAlert®, Mainz Biomed’s highly efficacious and easy-to-use screening test for CRC, for its corporate health program.
“We are incredibly pleased with these early results, as outcomes like these indicate what the future holds when patients have increased access to easy, convenient and affordable screening,” said Guido Baechler, Chief Executive Officer of Mainz Biomed.
As part of its commitment to the BGM program, Mainz Biomed provided education to employees and physicians on CRC and recommendations for next steps.
“Our employees are able to readily access the patient portal, request a kit and securely receive their results within five days.

Michele Baptista Joins CenExel

Retrieved on:

Giovedì, Maggio 18, 2023

Michele joins CenExel from WCG IRB, where she was a Business Development Director developing and selling ethical review services for all Phase 1, biotech, medical device, diagnostics, biologics, and social and behavioral research.

Key Points:

Michele joins CenExel from WCG IRB, where she was a Business Development Director developing and selling ethical review services for all Phase 1, biotech, medical device, diagnostics, biologics, and social and behavioral research.
Michele has also held other business development and administration positions in the clinical trial space working for Biomed IRB.
“We are thrilled to have Michele join our team as our new Senior Director of Business Development," said CenExel Chief Commercial Officer, Casey Orvin.
"Michele has been an active part of the industry for over 30 years, and we look forward to her joining our CenExel commercial team.

Anaconda Biomed Names New Chairperson, Appoints Chief Medical Officer

Retrieved on:

Giovedì, Aprile 20, 2023

Anaconda Biomed , a medical technology company developing next-generation thrombectomy systems, today announced the appointment of a new board chairperson, and the naming of a new chief medical officer.

Key Points:

Anaconda Biomed , a medical technology company developing next-generation thrombectomy systems, today announced the appointment of a new board chairperson, and the naming of a new chief medical officer.
He also led two publicly traded medical device firms, Cardiovascular Imaging Systems and CardioThoracic Systems, to successful nine-figure acquisitions as CEO.
In addition to Anaconda Biomed, he serves as chairman and board member of multiple medical device and biotech companies.
“Rich has dedicated more than two decades to bringing ground-breaking medical technologies into being, helping to better the lives of thousands of patients,” said Francois Salmon, CEO of Anaconda Biomed.